Correction to: Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations

被引：0
|
作者：
George G. Zhanel
Courtney K. Lawrence
Heather Adam
Frank Schweizer
Sheryl Zelenitsky
Michael Zhanel
Philippe R. S. Lagacé-Wiens
Andrew Walkty
Andrew Denisuik
Alyssa Golden
Alfred S. Gin
Daryl J. Hoban
Joseph P. Lynch
James A. Karlowsky
机构：
[1] University of Manitoba,Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine
[2] University of Manitoba,College of Pharmacy
[3] University of Manitoba,Department of Chemistry, Faculty of Science
[4] Winnipeg Health Sciences Centre,Department of Medicine
[5] Winnipeg Health Sciences Centre,Department of Pharmacy
[6] Diagnostic Services Manitoba,Division of Pulmonary, Critical Care, Allergy and Clinical Immunology
[7] The David Geffen School of Medicine at UCLA,undefined
来源：
Drugs | 2018年 / 78卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Section heading 5.2, which currently reads 5.2 Meropenem–Relebactam.
引用
收藏
页码：787 / 787
相关论文
共 50 条
  • [31] Correction to: Epidemiology and in vitro activity of ceftazidime–avibactam, meropenem–vaborbactam, imipenem–relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates
    Sofia Maraki
    Viktoria Eirini Mavromanolaki
    Eleni Magkafouraki
    Panagiotis Moraitis
    Dimitra Stafylaki
    Anna Kasimati
    Effie Scoulica
    Infection, 2022, 50 : 1639 - 1639
  • [32] In vitro activity of imipenem/relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli from Taiwan
    Kuo, Shu-Chen
    Wang, Yung-Chih
    Tan, Mei-Chen
    Huang, Wei-Cheng
    Shiau, Yih-Ru
    Wang, Hui-Ying
    Lai, Jui-Fen
    Huang, I-Wen
    Lauderdale, Tsai-Ling
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (08) : 2071 - 2078
  • [33] Colistin, Meropenem-Vaborbactam, Imipenem-Relebactam, and Eravacycline Testing in Carbapenem-Resistant Gram-Negative Rods: A Comparative Evaluation of Broth Microdilution, Gradient Test, and VITEK 2
    Forstner, Patrick
    Fuchs, Lisa
    Luxner, Josefa
    Grisold, Andrea
    Steinmetz, Ivo
    Dichtl, Karl
    ANTIBIOTICS-BASEL, 2024, 13 (11):
  • [34] Review of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem-Vaborbactam and Imipenem-Relebactam in Carbapenemase Producing Klebsiella pneumoniae Isolates
    Aydemir, Ozlem
    Koroglu, Mehmet
    Sahin, Elif Ozozen
    Vural, Sevinc
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2023, 12
  • [35] Effect of the β-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae
    Castanheira, Mariana
    Rhomberg, Paul R.
    Flamm, Robert K.
    Jones, Ronald N.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (09) : 5454 - 5458
  • [36] Klebsiella pneumoniae Mutants Resistant to Ceftazidime-Avibactam Plus Aztreonam, Imipenem-Relebactam, Meropenem-Vaborbactam, and Cefepime-Taniborbactam
    Satapoomin, Naphat
    Dulyayangkul, Punyawee
    Avison, Matthew B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (04)
  • [37] Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections
    Alonso-Garcia, Isaac
    Vazquez-Ucha, Juan Carlos
    Lasarte-Monterrubio, Cristina
    Gonzalez-Mayo, Elena
    Lada-Salvador, Paula
    Vela-Fernandez, Ramon
    Aja-Macaya, Pablo
    Guijarro-Sanchez, Paula
    Rumbo-Feal, Soraya
    Muino-Andrade, Maria
    Fernandez-Gonzalez, Ana
    Martinez-Guitian, Marta
    Beceiro, Alejandro
    Rodriguez-Iglesias, Manuel
    Oliver, Antonio
    Arca-Suarez, Jorge
    Galan-Sanchez, Fatima
    Bou, German
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (05) : 1195 - 1200
  • [38] In vitro activity of imipenem-relebactam against KPC-producing Klebsiella pneumoniae resistant to ceftazidime-avibactam and/or meropenem-vaborbactam
    Lombardo, Donatella
    Ambretti, Simone
    Lazzarotto, Tiziana
    Gaibani, Paolo
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (05) : 749 - 751
  • [39] In vitro activity of imipenem/relebactam and ceftazidime/avibactam against carbapenem- resistant Klebsiella pneumoniae from blood cultures in a University hospital in Serbia
    Zornic, Sanja
    Petrovic, Ivana
    Lukovic, Bojana
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2023, 70 (03) : 187 - 192
  • [40] In vitro Synergistic and Bactericidal Effects of Aztreonam in Combination with Ceftazidime/ Avibactam, Meropenem/Vaborbactam and Imipenem/ Relebactam Against Dual-Carbapenemase-Producing Enterobacterales
    Fu, Ying
    Zhu, Yufeng
    Zhao, Feng
    Yao, Bingyan
    Yu, Yunsong
    Zhang, Jun
    Chen, Qiong
    INFECTION AND DRUG RESISTANCE, 2024, 17 : 3851 - 3861
12345